February 2, 2017
The Federal Food & Drug Administration has granted approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of infant deaths, spinal muscular atrophy (SMA). The drug will treat kids and adults with all forms of spinal muscular atrophy (SMA) caused by a deficiency of SMN protein.
January 9, 2017
November 17, 2016
The Mansfield Golf Classic, a fundraiser for the Muscular Dystrophy Association, will take place June 6-7, 2017 at Reynolds Lake Oconee in Greensboro, GA.
April 19, 2016
In celebration of Mansfield's thirty-year partnership with MDA, country music star Kellie Pickler will perform live on Tuesday night, May 17th during the Concert on the Lawn sponsored by Fifth Third Bank.